Temixys

Active Ingredient(s): Lamivudine + Tenofovir Disoproxil Fumarate
FDA Approved: * November 16, 2018
Pharm Company: * CELLTRION INC
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Temixys Overview

Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS.[1] It is also used to treat chronic hepatitis B when other options are not possible.[1] It is effective against both HIV-1 and HIV-2.[1] It is typically used in combination with other antiretrovirals such as zidovudine and abacavir.[1] Lamivudine may be included as part of post-exposure prevention in those who have been potentiall...

Read more Temixys Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lamivudine

Recent Temixys Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lamivudine + Tenofovir Disoproxil Fumarate
  • Tablet: 300mg + 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Temixys: (2 results)

Sorted by National Drug Code
  • 32228-004 Temixys Oral Tablet, Film Coated by Celltrion, Inc.
  • 72606-002 Temixys Oral Tablet, Film Coated by Celltrion USA, Inc.

Drugs with one or more similar ingredients: (24 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA